Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epacadostat in Myelodysplastic Syndromes
NCT01822691Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Jul 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epacadostat in myelodysplastic syndrome (MDS), sponsored by Moffitt Cancer Center. Started Jul 2013; status: completed.
02
Drugs
epacadostat
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01822691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01822691.